Reimagining the Future of Cardiovascular Health
When Dr. Denton Cooley and his colleagues founded the Texas Heart Institute (THI), it was with the firm belief that excellence in...
Cardiomyocyte Renewal Laboratory
Texas Heart Institute Unites To Promote Cardiovascular Health on World Heart Day
Cardiovascular disease (CVD) remains the world’s number one killer, resulting in 18.6 million deaths a year. From well-known risk factors...
New Texas Heart Institute Study Outlines Additional Reasons for Optimism Related to Heart Regeneration
The New Paper Follows Closely on the Heels of a Related Publication on Cardiomyocyte Renewal Following a Heart Attack ...
Houston Chronicle Features Dr. Jim Martin’s ground breaking research aimed to change how we treat heart failure
Patients suffering from heart failure have very limited treatment options, and up to this point, it had essentially been impossible...
Groundbreaking Cardiovascular Gene Therapy Has Potential to Drastically Alter Outlook for Heart Failure Patients
Published in Science Translational Medicine – A Revolutionary New Game Plan for Treating Individuals Following a Heart Attack HOUSTON, TX...
Dr. James Martin – Director of the Cardiomyocyte Renewal Lab at Texas Heart Institute – Elected to the 2021 Class of the National Academy of Inventors
Houston, TX (February 11, 2021) – The Texas Heart Institute is pleased to announce that Dr. James Martin, Director of its...
Texas Heart Institute Members & Fellows Share Knowledge Globally to Advance the Field
“SCIENCE ISN’T FINISHED UNTIL IT IS COMMUNICATED.” – SIR MARK WALPERT Sharing scientific...
In Memoriam James T. Willerson, MD
It is with great sadness that we inform you of the passing of THI’s President Emeritus, Dr. James T....
Cardiology In The Time of COVID-19: Cell Therapy to Modulate Inflammation
In response to the evolving pandemic, the Texas Heart Institute (THI) is dedicating its education series, Innovative Technologies & Techniques, to providing...
